RayzeBio

San Diego,  CA 
United States
https://rayzebio.com/
  • Booth: 11119

RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. Established in 2020, RayzeBio is backed by a syndicate of sophisticated healthcare investors.